0.8920EUR+2.06%Mkt Cap: 67.12M $P/E: —1d ago
AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cance…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
1M Perf
Higher
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap67.12M $
Enterprise Value80.42M $
Revenue (TTM)1.28M $
Gross Profit1.06M $
Net Income (TTM)-1.69M $
Revenue/Share0.0207 USD
Last Price0.8920 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees26
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0010557264
Valuation
P/E (Trailing)—
P/E (Forward)-6.32
PEG—
EV/EBITDA99.31
EV/Revenue63.02
P/S52.60
P/B-3.77
EPS (TTM)-0.03
EPS (Forward)-0.14
52W Range
0.82907% of range1.730
52W High1.730 EUR
52W Low0.8290 EUR
Profitability
Gross Margin83.30%
Oper. Margin510.93%
EBITDA Margin63.46%
Profit Margin-132.62%
ROE9.05%
ROA-6.35%
Growth
Revenue Growth28.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.66M $
CapEx (TTM)306.52K $
FCF Margin143.03%
FCF Yield2.72%
Net Debt10.08M $
Net Debt/EBITDA12.44
Balance Sheet
Debt/Equity-1.10
Current Ratio0.96
Quick Ratio0.92
Book Value/Sh-0.2350 EUR
Cash/Share0.1390 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.485 EUR
Upside (mean)+402.8%
Target Range4.485 EUR – 4.485 EUR
# Analysts1
Ownership
Shares Out.69.78M
Float33.81M
Insiders29.22%
Institutions0.00%
Technical
SMA 500.9706 (-8.1%)
SMA 2001.198 (-25.5%)
Beta1.22
S&P 52W Chg20.05%
Avg Vol (30d)228.55K
Avg Vol (10d)208.78K
Technical Indicators
RSI (14)45.2
MACD-0.0278
MACD Signal-0.0340
MACD Hist.+0.0061
BB Upper0.9361 EUR
BB Middle0.8889 EUR
BB Lower0.8416 EUR
BB Width10.64%
ATR (14)0.0374 EUR
Vol Ratio (20d)0.41x